- Home
- Publications
- Publication Search
- Publication Details
Title
Follistatin Is a Novel Biomarker for Lung Adenocarcinoma in Humans
Authors
Keywords
Adenocarcinoma of the lung, Adenocarcinomas, Lung development, Lung and intrathoracic tumors, Adenocarcinoma cells, Apoptosis, Squamous cell lung carcinoma, Secondary lung tumors
Journal
PLoS One
Volume 9, Issue 10, Pages e111398
Publisher
Public Library of Science (PLoS)
Online
2014-10-28
DOI
10.1371/journal.pone.0111398
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Clinical Observations on the Association Between Diagnosis of Lung Cancer and Serum Tumor Markers in Combination
- (2013) Wen-Jing Wang et al. Asian Pacific Journal of Cancer Prevention
- Activin A inhibits activities of lipopolysaccharide-activated macrophages via TLR4, not of TLR2
- (2013) Nan Li et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- High Serum Levels of Follistatin in Patients with Ovarian Cancer
- (2013) P Ren et al. JOURNAL OF INTERNATIONAL MEDICAL RESEARCH
- Diagnostic value of CEA and CYFRA 21-1 tumor markers in primary lung cancer
- (2013) Kyoko Okamura et al. LUNG CANCER
- Follistatin as potential therapeutic target in prostate cancer
- (2013) Maria Vittoria Sepporta et al. Targeted Oncology
- Ectopic Cushing's syndrome caused by a pulmonary ACTH-secreting tumor in a patient treated with octreotide
- (2012) Pedro Rodrigues et al. Arquivos Brasileiros de Endocrinologia e Metabologia
- Effect of Boron on Osteogenic Differentiation of Human Bone Marrow Stromal Cells
- (2011) Xiaozhou Ying et al. BIOLOGICAL TRACE ELEMENT RESEARCH
- Antitumour efficacy of MEK inhibitors in human lung cancer cells and their derivatives with acquired resistance to different tyrosine kinase inhibitors
- (2011) F Morgillo et al. BRITISH JOURNAL OF CANCER
- Cushing syndrome secondary to ectopic adrenocorticotropic hormone secretion
- (2011) Shamim Ejaz et al. CANCER
- When versatility matters: activins/inhibins as key regulators of immunity
- (2011) G R Aleman-Muench et al. IMMUNOLOGY AND CELL BIOLOGY
- A Critical Role of Activin A in Maturation of Mouse Peritoneal Macrophages in vitro and in vivo
- (2010) Yinan Wang et al. Cellular & Molecular Immunology
- Serum follistatin in patients with prostate cancer metastatic to the bone
- (2010) Francesca Maria Tumminello et al. CLINICAL & EXPERIMENTAL METASTASIS
- Fifty years of cancer incidence: CI5 I-IX
- (2010) D. Max Parkin et al. INTERNATIONAL JOURNAL OF CANCER
- Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
- (2010) Jacques Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- Nucleolar Follistatin Promotes Cancer Cell Survival under Glucose-deprived Conditions through Inhibiting Cellular rRNA Synthesis
- (2010) Xiangwei Gao et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Reviews: Activins and Related Proteins in the Establishment of Pregnancy
- (2010) Pasquale Florio et al. Reproductive Sciences
- Activins and inhibins: Novel regulators of thymocyte development
- (2009) Paula Licona-Limón et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Differential Effects of Follistatin on Nonhuman Primate Oocyte Maturation and Pre-Implantation Embryo Development In Vitro1
- (2009) Catherine A. VandeVoort et al. BIOLOGY OF REPRODUCTION
- The New Lung Cancer Staging System
- (2009) Frank C. Detterbeck et al. CHEST
- Identification of Five Candidate Lung Cancer Biomarkers by Proteomics Analysis of Conditioned Media of Four Lung Cancer Cell Lines
- (2009) Chris Planque et al. MOLECULAR & CELLULAR PROTEOMICS
- Involvement of ERK, Bcl-2 family and caspase 3 in recombinant human activin A-induced apoptosis in A549
- (2009) Baiding Wang et al. TOXICOLOGY
- Follistatin Suppresses the Production of Experimental Multiple-Organ Metastasis by Small Cell Lung Cancer Cells in Natural Killer Cell-Depleted SCID Mice
- (2008) H. Ogino et al. CLINICAL CANCER RESEARCH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started